ABSTRACT
Understanding the functional potential of the gut microbiome is of primary importance for the design of innovative strategies for allergy treatment and prevention. Here we report the gut microbiome features of 90 children affected by food (FA) or respiratory (RA) allergies and 30 age-matched, healthy controls (CT). We identify specific microbial signatures in the gut microbiome of allergic children, such as higher abundance of Ruminococcus gnavus and Faecalibacterium prausnitzii, and a depletion of Bifidobacterium longum, Bacteroides dorei, B. vulgatus and fiber-degrading taxa. The metagenome of allergic children shows a pro-inflammatory potential, with an enrichment of genes involved in the production of bacterial lipo-polysaccharides and urease. We demonstrate that specific gut microbiome signatures at baseline can be predictable of immune tolerance acquisition. Finally, a strain-level selection occurring in the gut microbiome of allergic subjects is identified. R. gnavus strains enriched in FA and RA showed lower ability to degrade fiber, and genes involved in the production of a pro-inflammatory polysaccharide. We demonstrate that a gut microbiome dysbiosis occurs in allergic children, with R. gnavus emerging as a main player in pediatric allergy. These findings may open new strategies in the development of innovative preventive and therapeutic approaches. Trial: NCT04750980.
Subject(s)
Allergens/immunology , Food Hypersensitivity/microbiology , Gastrointestinal Microbiome/immunology , Immune Tolerance , Respiratory Hypersensitivity/microbiology , Allergens/adverse effects , Animals , Bacteroides/isolation & purification , Bacteroides/metabolism , Bifidobacterium longum/isolation & purification , Bifidobacterium longum/metabolism , Case-Control Studies , Child , Child, Preschool , Clostridiales/isolation & purification , Clostridiales/metabolism , Dander/adverse effects , Dander/immunology , Eggs/adverse effects , Faecalibacterium prausnitzii/isolation & purification , Faecalibacterium prausnitzii/metabolism , Female , Food Hypersensitivity/etiology , Food Hypersensitivity/immunology , Humans , Lipopolysaccharides/biosynthesis , Male , Milk/adverse effects , Milk/immunology , Nuts/adverse effects , Nuts/immunology , Pollen/chemistry , Pollen/immunology , Prunus persica/chemistry , Prunus persica/immunology , Pyroglyphidae/chemistry , Pyroglyphidae/immunology , Respiratory Hypersensitivity/etiology , Respiratory Hypersensitivity/immunology , Urease/biosynthesisABSTRACT
BACKGROUND: Obesity worsens airway hyperresponsiveness (AHR) in asthmatic subjects by up-regulating macrophage polarization that leads to excessive secretion of pro-inflammatory adipokines from white adipose tissue followed by generation of oxidative stress in the respiratory system. Treatment through conventional signaling pathways proved to be inadequate in obese asthmatics, so a therapeutical approach through a non-conventional pathway may prove to be effective. PURPOSE: This study aimed to investigate the efficacy of a FDA-approved food additive, ß-caryophyllene (BCP) in obesity-associated AHR. METHOD: A repertoire of protein expression, cytokine and adiponectin estimation, oxidative stress assays, histopathology, and fluorescence immune-histochemistry were performed to assess the efficacy of BCP in C57BL/6 mice model of obesity-associated AHR. Additionally, human adipocyte was utilized to study the effect of BCP on macrophage polarization in Boyden chamber cell culture inserts. RESULTS: Obesity-associated AHR is ameliorated by administration of BCP by inhibition of the macrophage polarization by activation of AMPKα, Nrf2/HO-1 and AdipoR1 and AdipoR2 signaling pathway, up-regulation of adiponectin, GLP-1, IFN-γ, SOD, catalase and down-regulation of NF-κB, leptin, IL-4, TNF, and IL-1ß. Browning of eWAT by induction of thermogenesis and activation of melanocortin pathway also contributed to the amelioration of obesity-associated AHR. We conclude that BCP ameliorated the obesity-associated AHR via inhibition of macrophage polarization, activation of AMPKα, Nrf2/HO-1, and up-regulation of AdipoR1 and AdipoR2 expression and down-regulation of NFκB expression in lung of animal. CONCLUSION: Being an FDA-approved food additive, BCP may prove to be a safe and potential agent against obesity-associated AHR.
Subject(s)
Adipocytes/drug effects , Obesity , Polycyclic Sesquiterpenes/pharmacology , Respiratory Hypersensitivity , Animals , Cells, Cultured , Humans , Mice , Mice, Inbred C57BL , Obesity/complications , Obesity/drug therapy , Respiratory Hypersensitivity/drug therapy , Respiratory Hypersensitivity/etiologyABSTRACT
Vitamin D (VitD) has pleiotropic effects. VitD deficiency is closely involved with obesity and may contribute to the development of lung fibrosis and aggravation of airway hyperresponsiveness (AHR). We evaluated the causal relationship between VitD deficiency and the lung pathologies associated with obesity. In vivo effects of VitD supplementation were analyzed using high-fat diet (HFD)-induced obese mice and TGF-ß1 (transforming growth factor-ß1) triple transgenic mice. Effects of VitD supplementation were also evaluated in both BEAS-2B and primary lung cells from the transgenic mice. Obese mice had decreased 25-OH VitD and VitD receptor expressions with increases of insulin resistance, renin and angiotensin-2 system (RAS) activity, and leptin. In addition, lung pathologies such as a modest increase in macrophages, enhanced TGF-ß1, IL-1ß, and IL-6 expression, lung fibrosis, and AHR were found. VitD supplementation to HFD-induced obese mice recovered these findings. TGF-ß1-overexpressing transgenic mice enhanced macrophages in BAL fluid, lung expression of RAS, epithelial-mesenchymal transition markers, AHR, and lung fibrosis. VitD supplementation also attenuated these findings in addition to the attenuation of the expressions of TGF-ß1, and phosphorylated Smad-2/3 in lung. Supplementing in vitro-stimulated BEAS-2B and primary lung cells with VitD inhibited TGF-ß1 expression, supporting the suppressive effect of VitD for TGF-ß1 expression. These results suggest that obesity leads to VitD deficiency and worsens insulin resistance while enhancing the expression of leptin, RAS, TGF-ß1, and proinflammatory cytokines. These changes may contribute to the development of lung fibrosis and AHR. VitD supplementation rescues these changes and may have therapeutic potential for asthma with obesity.
Subject(s)
Obesity/complications , Pulmonary Fibrosis/etiology , Respiratory Hypersensitivity/etiology , Vitamin D Deficiency/etiology , Animals , Biomarkers/metabolism , Body Weight/drug effects , Cells, Cultured , Cytokines/metabolism , Diet, High-Fat , Dietary Supplements , Epithelial-Mesenchymal Transition/drug effects , Glucose Tolerance Test , Inflammation/pathology , Insulin/metabolism , Leptin/blood , Lung/metabolism , Lung/pathology , Male , Methacholine Chloride , Mice, Inbred C57BL , Mice, Transgenic , Obesity/blood , Pulmonary Fibrosis/blood , Receptors, Calcitriol/metabolism , Renin/blood , Renin-Angiotensin System/drug effects , Respiratory Hypersensitivity/blood , Transforming Growth Factor beta1/metabolism , Vitamin D/analogs & derivatives , Vitamin D/blood , Vitamin D/pharmacology , Vitamin D Deficiency/bloodABSTRACT
Studies demonstrated that pneumonia can decrease vitamin A productions and vitamin A reduction/deficiency may promote asthma development. Our previous study showed that neonatal Streptococcus pneumoniae (S. pneumoniae) infection promoted asthma development. Whether neonatal S. pneumoniae pneumonia induced asthma was associated with vitamin A levels remains unclear. The aim of this study was to investigate the effects of neonatal S. pneumoniae pneumonia on vitamin A expressions, to explore the effects of vitamin A supplement after neonatal S. pneumoniae pneumonia on adulthood asthma development. Non-lethal S. pneumoniae pneumonia was established by intranasal inoculation of neonatal (1-week-old) female BALB/c mice with D39. S. pneumoniae pneumonia mice were supplemented with or without all-trans retinoic acid 24 hours after infection. Vitamin A concentrations in lung, serum and liver were measured post pneumonia until early adulthood. Four weeks after pneumonia, mice were sensitized and challenged with OVA to induce allergic airway disease (AAD). Twenty-four hours after the final challenge, the lungs and bronchoalveolar lavage fluid (BALF) were collected to assess AAD. We stated that serum vitamin A levels in neonatal S. pneumoniae pneumonia mice were lower than 0.7µmol/L from day 2-7 post infection, while pulmonary vitamin A productions were significantly lower than those in the control mice from day 7-28 post infection. Vitamin A supplement after neonatal S. pneumoniae pneumonia significantly promoted Foxp3+Treg and Th1 productions, decreased Th2 and Th17 cells expressions, alleviated airway hyperresponsiveness (AHR) and inflammatory cells infiltration during AAD. Our data suggest that neonatal S. pneumoniae pneumonia induce serum vitamin A deficiency and long-time lung vitamin A reduction, vitamin A supplement after neonatal S. pneumoniae pneumonia inhibit the progression of asthma by altering CD4+T cell subsets.
Subject(s)
Asthma/prevention & control , Dietary Supplements , Pneumonia, Pneumococcal/complications , Respiratory Hypersensitivity/prevention & control , Streptococcus pneumoniae/immunology , T-Lymphocyte Subsets/immunology , Vitamin A/administration & dosage , Animals , Animals, Newborn , Asthma/etiology , Asthma/metabolism , Asthma/pathology , Female , Mice , Mice, Inbred BALB C , Pneumonia, Pneumococcal/drug therapy , Pneumonia, Pneumococcal/metabolism , Respiratory Hypersensitivity/etiology , Respiratory Hypersensitivity/metabolism , Respiratory Hypersensitivity/pathology , Streptococcus pneumoniae/isolation & purification , T-Lymphocyte Subsets/drug effects , T-Lymphocytes, Regulatory/drug effects , T-Lymphocytes, Regulatory/immunology , Vitamin A/metabolism , Vitamins/administration & dosage , Vitamins/metabolismABSTRACT
Lipid mediators derived from omega (n)-3 and n-6 long-chain polyunsaturated fatty acids (LCPUFA) play key roles in bronchoconstriction, airway inflammation, and resolution processes in asthma. This study compared the effects of dietary supplementation with either a combination of LCPUFAs or eicosapentaenoic acid (EPA) alone to investigate whether the combination has superior beneficial effects on the outcome of asthmatic mice. Mice were sensitized with house dust mite (HDM) extract, and subsequently supplemented with either a combination of LCPUFAs or EPA alone in a recall asthma model. After the final HDM and LCPUFA administration, airway hyperresponsiveness (AHR), bronchoalveolar lavages, and lung histochemistry were examined. Lipid mediator profiles were determined by liquid chromatography coupled with tandem mass spectrometry (LC-MS-MS). The LCPUFA combination reduced AHR, eosinophilic inflammation, and inflammatory cytokines (IL-5, IFN-γ, and IL-6) in asthmatic mice, whereas EPA enhanced inflammation. The combination of LCPUFAs was more potent in downregulating EPA-derived LTB5 and LTC5 and in supporting DHA-derived RvD1 and RvD4 (2.22-fold and 2.58-fold higher levels) than EPA alone. Ex vivo experiments showed that LTB5 contributes to granulocytes' migration and M1-polarization in monocytes. Consequently, the LCPUFA combination ameliorated airway inflammation by inhibiting adverse effects of EPA and promoting pro-resolving effects supporting the lipid mediator-dependent resolution program.
Subject(s)
Anti-Inflammatory Agents/administration & dosage , Asthma/etiology , Eicosapentaenoic Acid/adverse effects , Fatty Acids, Unsaturated/administration & dosage , Allergens/immunology , Animals , Anti-Inflammatory Agents/chemistry , Asthma/drug therapy , Asthma/metabolism , Asthma/pathology , Biopsy , Biosynthetic Pathways/drug effects , Cell Membrane/drug effects , Cell Membrane/metabolism , Cyclooxygenase 2/metabolism , Dietary Supplements , Disease Models, Animal , Fatty Acids, Unsaturated/chemistry , Immunization , Immunohistochemistry , Leukotrienes/biosynthesis , Mice , Pyroglyphidae/immunology , Respiratory Hypersensitivity/drug therapy , Respiratory Hypersensitivity/etiology , Respiratory Hypersensitivity/metabolism , Respiratory Hypersensitivity/pathologyABSTRACT
OBJECTIVE: Allergy is a very common condition. Allergic disease is highly affected by environmental changes. Conditions of the four seasons can change dramatically in Republic of Korea (ROK). To assess changes in rates of aeroallergen positivity according to seasons and environmental factors (temperature, humidity, and precipitation). MATERIALS: A total of 20 hospitals were selected based on population distribution in ROK. A skin prick test (SPT) panel comprising 55 aeroallergens was distributed to 18 hospitals for a prospective study. Results from SPTs done in 2006 and 2010 were collected and analyzed retrospectively from 20 hospitals and 2014/2015 SPT (from June 2014 to May 2015) results from 18 hospitals were collected prospectively. RESULTS: We compared allergen-positive rates among seasons. Positive test rates for several pollens and house dust mites increased significantly in spring and fall. Pollens positive rate varied significantly according to temperature, precipitation, and humidity while mite allergens were less susceptible to environment. CONCLUSION: There are four distinct seasons in ROK. The positivity of pollen allergens were especially affected by temperature and precipitation in spring. House dust mites were less affected by seasons, temperature, precipitation, and humidity less than pollen. Therefore, regular follow-up and re-evaluation of allergic test are essential considering changes of seasons and environment for acceptable diagnosis and treatment.
Subject(s)
Allergens/adverse effects , Humidity , Rain , Respiratory Hypersensitivity/diagnosis , Respiratory Hypersensitivity/epidemiology , Seasons , Temperature , Adolescent , Adult , Aged , Aged, 80 and over , Animals , Animals, Domestic , Child , Child, Preschool , Female , Humans , Insecta , Male , Middle Aged , Plant Weeds , Poaceae , Pollen , Prospective Studies , Pyroglyphidae , Republic of Korea/epidemiology , Respiratory Hypersensitivity/etiology , Skin Tests , Trees , Young AdultABSTRACT
Obesity is a risk factor for asthma, especially nonatopic asthma, and attenuates the efficacy of standard asthma therapeutics. Obesity also augments pulmonary responses to ozone, a nonatopic asthma trigger. The purpose of this study was to determine whether obesity-related alterations in gut microbiota contribute to these augmented responses to ozone. Ozone-induced increases in airway responsiveness, a canonical feature of asthma, were greater in obese db/db mice than in lean wild-type control mice. Depletion of gut microbiota with a cocktail of antibiotics attenuated obesity-related increases in the response to ozone, indicating a role for microbiota. Moreover, ozone-induced airway hyperresponsiveness was greater in germ-free mice that had been reconstituted with colonic contents of db/db than in wild-type mice. In addition, compared with dietary supplementation with the nonfermentable fiber cellulose, dietary supplementation with the fermentable fiber pectin attenuated obesity-related increases in the pulmonary response to ozone, likely by reducing ozone-induced release of IL-17A. Our data indicate a role for microbiota in obesity-related increases in the response to an asthma trigger and suggest that microbiome-based therapies such as prebiotics may provide an alternative therapeutic strategy for obese patients with asthma.
Subject(s)
Gastrointestinal Microbiome/physiology , Obesity/complications , Ozone/toxicity , Respiratory Hypersensitivity/etiology , Airway Resistance , Animals , Anti-Bacterial Agents/pharmacology , Anti-Bacterial Agents/therapeutic use , Asthma/etiology , Asthma/therapy , Cellulose/administration & dosage , Dietary Fiber/administration & dosage , Fecal Microbiota Transplantation , Female , Fermentation , Gastrointestinal Microbiome/drug effects , Germ-Free Life , Mice , Mice, Inbred C57BL , Mice, Obese , Obesity/genetics , Obesity/microbiology , Obesity/physiopathology , Pectins/administration & dosage , Pectins/therapeutic use , Receptors, Leptin/deficiency , Respiratory Hypersensitivity/chemically induced , Respiratory Hypersensitivity/diet therapy , Respiratory Hypersensitivity/microbiologyABSTRACT
OBJECTIVE: To investigate the effect of vitamin D supplementation dose on allergic sensitization and allergic diseases in infants, and to evaluate whether vitamin D status in pregnancy and at birth are associated with infant allergy outcomes. STUDY DESIGN: Altogether, 975 infants participated in a randomized, controlled trial of daily vitamin D supplementation of 10 µg (400 IU) or 30 µg (1200 IU) from the age of 2 weeks. At 12 months of age, food and aeroallergen IgE antibodies were measured, and the occurrence of allergic diseases and wheezing were evaluated. RESULTS: We found no differences between the vitamin D supplementation groups in food (OR, 0.98; 95% CI, 0.66-1.46) or aeroallergen sensitization at 12 months (OR, 0.76; 95% CI,0.34-1.71). Allergic diseases or wheezing did not differ between groups, except for milk allergy which occurred more often in infants administered 30 µg vitamin D compared with the 10 µg dose (OR, 2.23; 95% CI, 1.00-4.96). Infants with high cord blood 25-hydroxyvitamin D (≥100 nmol/L) had a higher risk of food allergen sensitization compared with those with lower 25(OH)D concentration (75-99.9 nmol/L; OR, 2.00; 95% CI, 1.19-3.39). CONCLUSIONS: High-dose vitamin D supplementation did not prevent allergic sensitization, allergic diseases, or wheezing during the first year of life. In contrast, we observed an increased risk of milk allergy in infants randomized to higher vitamin D supplementation, and an increased risk of allergic sensitization in infants with high cord blood vitamin D status, indicating a possible adverse effect of high concentrations of vitamin D.
Subject(s)
Dietary Supplements , Food Hypersensitivity/prevention & control , Respiratory Hypersensitivity/prevention & control , Vitamin D/administration & dosage , Vitamins/administration & dosage , Allergens/adverse effects , Double-Blind Method , Female , Food Hypersensitivity/etiology , Humans , Infant , Infant, Newborn , Male , Pregnancy , Respiratory Hypersensitivity/etiology , Treatment Failure , Vitamin D/bloodABSTRACT
PURPOSE: The goal of this study was to present the results of treatment of 100 chemically sensitive and chronically mold-exposed patients, who continued to be disabled even after decontamination of their houses or work places or they were physically removed from their sources of mold. METHODS: Molds were identified, serum anti-mold immunoglobulin G antibodies were measured, patients were skin-tested, immunologic abnormalities were recorded, and objective neurologic tests were performed in a subset of patients. FINDINGS: Patient sensitivities and exposures were confirmed by measuring serum immunoglobulin G anti-mold antibodies, intradermal skin testing, and trichothecene toxin breakdown products in the urine. Patients were positive (44%-98%) for individual molds. Abnormalities in T and B cells were found in >80% of patients. Respiratory signs were present in 64% of all patients, and physical signs and symptoms of neurologic dysfunction were present in 70%. Objective autonomic nervous system test results were abnormal in almost 100% of patients tested. Objective neuropsychological evaluations were conducted in 46 of the patients who exhibited symptoms of neurologic impairment and showed typical abnormalities in short-term memory, executive function/judgment, concentration, and hand/eye coordination. Patients (N = 100) with documented mold exposure were divided into 3 groups: (1) those who improved easily, with mold avoidance and antigen injections; (2) those who improved after desensitization to their mold antigens plus additional mycotoxin antigens; and (3) those who had their regular mold antigens, additional mycotoxin antigens, along with regimens that included sauna, oxygen therapy, and nutrients. Approximately 85% of all patients cleared completely; 14% had partial improvement, and 1% remained unchanged. IMPLICATIONS: Exposure to molds has been increasingly recognized as a major reason for patients presenting with multiple organ symptoms that could not otherwise be explained. Early diagnosis and appropriate treatment could be very successful.
Subject(s)
Environmental Exposure/adverse effects , Fungi/immunology , Mycotoxins/toxicity , Neurotoxicity Syndromes , Respiratory Hypersensitivity , Adult , Aged , Air Pollution, Indoor/adverse effects , Antigens, Fungal/administration & dosage , B-Lymphocytes/immunology , Desensitization, Immunologic , Female , Humans , Immunoglobulin G/blood , Male , Middle Aged , Mycotoxins/urine , Neurotoxicity Syndromes/etiology , Neurotoxicity Syndromes/immunology , Neurotoxicity Syndromes/therapy , Oxygen/therapeutic use , Respiratory Hypersensitivity/etiology , Respiratory Hypersensitivity/immunology , Respiratory Hypersensitivity/therapy , Steam Bath , T-Lymphocytes/immunology , Treatment Outcome , Young AdultABSTRACT
Many flavours and fragrances are known allergens. Their selection and inclusion levels in e-liquids must therefore be guided by toxicological principles, taking into account the exposure pattern and inhalation route of exposure. For contact sensitisation, a general, agreed quantitative risk assessment approach to prevent dermal sensitisation exists. Here we propose exposure parameters and safety factors to apply this approach to e-liquid ingredients. Additionally, as a risk management approach for pre-sensitised individuals, we derive a threshold of 0.1% for indicating the presence of a contact sensitiser in e-liquid. Risk assessment for respiratory sensitisation is not well established. Occupational exposure limits that protect against respiratory allergy are generally very low. Cocoa shell extract is used as a case study to discuss the issues. A tolerable exposure level is derived and estimates of consumer exposure are presented, leading to the practical risk management approach of excluding respiratory sensitisers as e-liquid ingredients. Related to this, if natural extracts are used as flavourings in e-liquids, we recommend only protein-free versions are used. Additionally, we recommend the presence of any potential food allergens should be noted on the product information.
Subject(s)
Allergens/adverse effects , Cacao/chemistry , Electronic Nicotine Delivery Systems , Hypersensitivity/etiology , Plant Extracts/adverse effects , Humans , Hypersensitivity, Immediate/etiology , Occupational Exposure , Respiratory Hypersensitivity/etiology , Risk AssessmentABSTRACT
OBJECTIVE: To recapitulate the more recent epidemiologic studies on the association of air pollution with respiratory allergic diseases prevalence and to discuss the main limitations of current approaches used to establish a link between pollinosis and pollution. DATA SOURCES: Through the use of PubMed, we conducted a broad literature review in the following areas: epidemiology of respiratory allergic diseases, effect of pollution and climate changes on pollen grains, and immunomodulatory properties of pollen substances. STUDY SELECTIONS: Studies on short- and long-term exposure to air pollutants, such as gaseous and particulate materials, on allergic sensitization, and on exacerbation of asthma symptoms were considered. RESULTS: Trend in respiratory allergic disease prevalence has increased worldwide during the last 3 decades. Although recent epidemiologic studies on a possible association of this phenomenon with increasing pollution are controversial, botanic studies suggest a clear effect of several pollutants combined to climatic changes on the increased expression of allergenic proteins in several pollen grains. The current literature suggests the need for considering both pollen allergen and pollutant contents for epidemiologic evaluation of environmental determinants in respiratory allergies. We propose that a measure of allergenic potential of pollens, indicative of the increase in allergenicity of a polluted pollen, may be considered as a new risk indicator for respiratory health in urban areas. CONCLUSION: Because public greens are located in strict proximity to the anthropogenic sources of pollution, the identification of novel more reliable parameters for risk assessment in respiratory allergic diseases is an essential need for public health management and primary prevention area.
Subject(s)
Air Pollutants/adverse effects , Air Pollution/adverse effects , Allergens/immunology , Pollen/immunology , Respiratory Hypersensitivity/epidemiology , Respiratory Hypersensitivity/etiology , Climate , Environmental Exposure/adverse effects , Humans , Immunization , Immunoglobulin E/immunology , Rhinitis, Allergic, Seasonal/epidemiology , Rhinitis, Allergic, Seasonal/etiology , Th2 Cells/immunology , Th2 Cells/metabolismABSTRACT
Schisandra chinensis (S. chinensis) is a traditional Chinese medicine commonly used in prescription medications for the treatment of chronic cough. However, the material basis of S. chinensis in relieving cough has not been completely elucidated yet. This study established a guinea pig model of cough hypersensitivity induced by 14 days of cigarette smoke (CS) exposure, to evaluate the antitussive, antioxidant, and anti-inflammatory effects of three S. chinensis extracts. And then the function of four lignans in reducing expression of TRPV1 and TRPA1 was examined using A549 cells induced by cigarette smoke extract (CSE). The results demonstrated that both ethanol extract (EE) and ethanol-water extract (EWE) of S. chinensis, but not water extract (WE), significantly reduced the cough frequency enhanced by 0.4M citric acid solution in these cough hypersensitivity guinea pigs. Meanwhile, pretreatment with EE and EWE both significantly attenuated the CS-induced increase in infiltration of pulmonary neutrophils and total inflammatory cells, as well as pulmonary MDA, TNF-α, and IL-8, while remarkably increased activities of pulmonary SOD and GSH. According to H&E and immunofluorescence staining assays, airway epithelium hyperplasia, smooth muscle thickening, inflammatory cells infiltration, as well as expression of TRPV1 and TRPA1, were significantly attenuated in animals pretreatment with 1g/kg EE. Moreover, four lignans of EE, including schizandrin, schisantherin A, deoxyschizandrin and γ-schisandrin, significantly inhibited CSE-induced expression of TRPV1, TRPA1 and NOS3, as well as NO release in A549 cells. In conclusion, S. chinensis reduces cough frequency and pulmonary inflammation in the CS-induced cough hypersensitivity guinea pigs. Lignans may be the active components.
Subject(s)
Antitussive Agents/therapeutic use , Cough/drug therapy , Drugs, Chinese Herbal/therapeutic use , Respiratory Hypersensitivity/drug therapy , Schisandra/chemistry , Tobacco Smoke Pollution/adverse effects , Animals , Anti-Inflammatory Agents/therapeutic use , Antioxidants/therapeutic use , Cell Line, Tumor , Chemokines/analysis , Chromatography, High Pressure Liquid , Cough/etiology , Cytokines/analysis , Disease Models, Animal , Drugs, Chinese Herbal/isolation & purification , Fruit/chemistry , Guinea Pigs , Inhalation Exposure/adverse effects , Lung Neoplasms/drug therapy , Male , Respiratory Hypersensitivity/etiology , Respiratory System/chemistryABSTRACT
INTRODUCTION: There is growing evidence to support an increase in air temperature over recent decades, with significant effects on aeroallergens such as pollen. It is generally accepted that the trend will continue, and become even more pronounced in the future. BACKGROUND: Global climate change is already affecting, and will continue to affect, with earlier floral initiation, the timing of the production of allergenic pollen. In addition, a warmer climate might lead to a longer pollen season and more days with high pollen counts. It could also increase the allergen content of pollens, and result in extension of plant species towards the poles and higher altitudes. Finally, rising levels of atmospheric CO2 are likely to reinforce these trends. VIEWPOINT: These predictions are subject to uncertainties that may lead to outcomes that differ materially from what is expected. Understanding the magnitude and direction of the changes affecting pollinisation is critical in order to quantify the future allergic disease burden and model the impacts of different climate change scenarios. CONCLUSIONS: Climate change influences the production, distribution, dispersion and allergenicity of anemophilous pollen and the growth and distribution of weeds, grasses and trees that produce it. These changes in aeroallergens and subsequent human exposure could affect the prevalence and severity of allergic disorders. There is, therefore, an important public health issue that requires development and implementation of appropriate response strategies without delay.
Subject(s)
Climate Change , Pollination/physiology , Allergens/immunology , France , Humans , Pollen/immunology , Respiratory Hypersensitivity/etiology , Respiratory Hypersensitivity/immunology , Seasons , Time FactorsSubject(s)
Hot Temperature , Hydrotherapy/adverse effects , Mycobacterium Infections/diagnosis , Mycobacterium avium/physiology , Respiratory Hypersensitivity/diagnosis , Balneology , Female , Hot Temperature/adverse effects , Humans , Mycobacterium Infections/etiology , Mycobacterium Infections/microbiology , Mycobacterium avium/growth & development , Mycobacterium avium/isolation & purification , Respiratory Hypersensitivity/etiology , Respiratory Hypersensitivity/microbiology , Young AdultSubject(s)
Allergens/immunology , Antigens, Plant/adverse effects , Food Hypersensitivity/etiology , Mentha/adverse effects , Respiratory Hypersensitivity/etiology , Adult , Allergens/adverse effects , Angioedema , Antigens, Plant/immunology , Antigens, Plant/isolation & purification , Eating , Female , Food Hypersensitivity/diagnosis , Humans , Immunoglobulin E/immunology , Immunoglobulin E/metabolism , Oils, Volatile/adverse effects , Plant Extracts , Plant Leaves/adverse effects , Respiratory Hypersensitivity/diagnosis , Skin TestsABSTRACT
Previous studies have shown that ragweed pollen arrives in Poland from sources in the south, in Slovakia, the Czech Republic, Hungary and Austria. It is likely that ragweed pollen also arrives from sources in the southeast (e.g. Ukraine). This hypothesis was investigated using 13 years of pollen data and back-trajectory analysis. Ambrosia pollen data were collected at three sites in Poland, Rzeszów, Kraków and Poznan. The amount of ragweed pollen recorded at Rzeszów was significantly higher than in Poznan and Kraków. This can be related to either a higher abundance of local populations of Ambrosia in south-east Poland or the proximity of Rzeszów to foreign sources of ragweed pollen. The combined results of pollen measurements and air mass trajectory calculations identified plumes of Ambrosia pollen that were recorded at Rzeszów, Kraków and Poznan on 4 and 5 September 1999 and 3 September 2002. These plumes arrived at the pollen-monitoring sites from an easterly direction, indicating sources of Ambrosia pollen in eastern Poland or Ukraine. This identifies Ukraine as a possible new source of ragweed pollen for Poland and therefore an important source area of Ambrosia pollen on the European Continent.
Subject(s)
Allergens/analysis , Ambrosia/adverse effects , Pollen/adverse effects , Air Movements , Allergens/adverse effects , Ambrosia/immunology , Climate , Humans , Meteorological Concepts , Poland , Pollen/immunology , Respiratory Hypersensitivity/etiology , Seasons , UkraineABSTRACT
Pollen plays an important role in the development and exacerbation of allergic diseases. We aimed to investigate the days with highest counts of the most allergenic pollens and to identify the meteorological factors affecting pollen counts in the atmosphere of Ankara, Turkey. Airborne pollen measurements were carried out from 2005 to 2008 with a Burkard volumetric 7-day spore trap. Microscope counts were converted into atmospheric concentrations and expressed as pollen grains/m(3). Meteorological parameters were obtained from the State Meteorological Service. All statistical analyses were done with pollen counts obtained from March to October for each year. The percentages of tree, grass and weed pollens were 72.1% (n = 24,923), 12.8% (n = 4,433) and 15.1% (n = 5,219), respectively. The Pinaceae family from tree taxa (39% to 57%) and the Chenopodiaceae/Amaranthaceae family from weed taxa, contributed the highest percentage of pollen (25% to 43%), while from the grass taxa, only the Poaceae family was detected from 2005 to 2008. Poaceae and Chenopodiaceae/Amaranthaceae families, which are the most allergenic pollens, were found in high numbers from May to August in Ankara. In multiple logistic regression analysis, wind speed (OR = 1.18, CI95% = 1.02-1.36, P = 0.023) for tree pollen, daily mean temperature (OR = 1.10, CI95% = 1.04-1.17, P = 0.001) and sunshine hours (OR = 1.15, CI95% = 1.01-1.30, P = 0.033) for grass pollen, and sunshine hours (OR = 3.79, CI95% = 1.03-13.92, P = 0.044) for weed pollen were found as significant risk factors for high pollen count. The pollen calendar and its association with meteorological factors depend mainly on daily temperature, sunshine hours and wind speed, which may help draw the attention of physicians and allergic patients to days with high pollen counts.
Subject(s)
Meteorological Concepts , Pollen/adverse effects , Allergens/adverse effects , Allergens/analysis , Humans , Logistic Models , Particulate Matter/adverse effects , Particulate Matter/analysis , Plant Weeds , Poaceae , Respiratory Hypersensitivity/etiology , Risk Factors , Species Specificity , Trees , TurkeyABSTRACT
In recent years, thanks to advances in molecular biology, allergological diagnosis has improved and specific IgE (sIgE) against an allergenic source has been transformed into sIgE against an allergenic protein or glycoprotein. This change, which has resulted in a more precise diagnosis of sensitisation, could explain the different dangers of certain molecular sensitisations and in many cases cross-reactivity phenomena, and could change indications for immunotherapy or clinical management. Here, we present two cases of children where the indication for immunotherapy and management of the disorder changed due to component-resolved diagnosis. However, the clinical history and skin prick tests should complement molecular in vitro diagnosis to improve routine clinical practice.
Subject(s)
Allergens , Hypersensitivity/diagnosis , Immunoglobulin E/immunology , Microarray Analysis , Allergens/immunology , Allergens/isolation & purification , Animals , Antigens, Dermatophagoides , Child , Child, Preschool , Dermatophagoides pteronyssinus/immunology , Desensitization, Immunologic , Diagnosis, Differential , Food Hypersensitivity/diagnosis , Food Hypersensitivity/etiology , Fruit/adverse effects , Humans , Hypersensitivity/etiology , Latex Hypersensitivity/diagnosis , Male , Pollen/adverse effects , Respiratory Hypersensitivity/diagnosis , Respiratory Hypersensitivity/etiology , Respiratory Hypersensitivity/therapy , Shellfish/adverse effects , Skin TestsABSTRACT
BACKGROUND: Allergen-specific immunotherapy, subcutaneous immunotherapy (SCIT) or oral, has been used for almost a century to redirect inappropriate immune responses in atopic patients. A new mode of administration through the intact skin [epicutaneous immunotherapy (EPIT)], using an original epicutaneous delivery system, may represent an alternative to these classical methods. OBJECTIVE: Proof of concept of efficacy of EPIT on intact skin in mice sensitized to aeroallergens or food allergens. METHODS: Mice were sensitized to pollen (n=18), house dust mite (HDM, n=24), ovalbumin (OVA, n=18) or peanut (n=18), and allocated to four groups: EPIT, SCIT, not treated (NT) and control. Specific Ig (sIg)E, sIgG1 and sIgG2a were monitored. After 8 weeks of treatment, plethysmography was performed after aerosol provocation with appropriate allergens. RESULTS: At the highest doses of methacholine, pause enhancement (Penh) values were significantly decreased in the EPIT group vs. the sensitized NT groups (7.5 vs. 12.3 - pollen, 7.6 vs. 8.9 - HDM, 11.5 vs. 14.5 - OVA, 7.6 vs. 12.8 - peanut, respectively) (P<0.05). With all the allergens tested, Penh values were similar in SCIT, EPIT and control. IgG2a for pollen, HDM, OVA and peanuts were significantly increased in the EPIT group vs. NT: 0.97 vs. 0.42 microg/mL, 2.5 vs. 0.46 microg/mL, 0.39 vs. 0.05 microg/mL and 15.0 vs. 5.5 microg/mL, respectively (P<0.05). There were no significant differences between EPIT and SCIT groups. The IgE/IgG2a ratio decreased significantly in the EPIT group for the four allergens from 70 to 58 (pollen), 175 to 26 (HDM), 5433 to 120 (OVA) and 49 to 6 (peanut), respectively (P<0.05). CONCLUSION: In mice sensitized to the four allergens tested, EPIT was as efficacious as SCIT, considered as the reference immunotherapy. These first results have to be confirmed by clinical studies.
Subject(s)
Desensitization, Immunologic/methods , Food Hypersensitivity , Respiratory Hypersensitivity , Skin/immunology , Animals , Arachis/immunology , Disease Models, Animal , Food Hypersensitivity/etiology , Food Hypersensitivity/immunology , Food Hypersensitivity/therapy , Humans , Hypersensitivity, Immediate/etiology , Hypersensitivity, Immediate/immunology , Hypersensitivity, Immediate/therapy , Mice , Mice, Inbred BALB C , Ovalbumin/administration & dosage , Ovalbumin/immunology , Peanut Hypersensitivity/etiology , Peanut Hypersensitivity/immunology , Peanut Hypersensitivity/therapy , Pollen/immunology , Pyroglyphidae/immunology , Respiratory Hypersensitivity/etiology , Respiratory Hypersensitivity/immunology , Respiratory Hypersensitivity/therapy , Treatment OutcomeABSTRACT
Pollen allergy currently affects a fifth of the population. A warmer climate will lead to a longer pollen season and more days with high pollen counts. In addition, a warmer climate increases the risk of proliferation of new plants with well-known allergenic pollens like ragweed, plane tree and wall pellitory, which have not previously caused allergy in Denmark. The consequences will be more people with hay fever and pollen asthma, longer allergy seasons and an increase in the severity of symptoms, disease-related costs and demands on health care for diagnosis and treatment of more complex allergies.